Skip to main content
NewslettersWatchlist

Stocks in play: WELL Health Technologies Corp.

Baystreet.ca - Baystreet - Wed Aug 14, 10:01AM CDT

Announced its interim consolidated financial results for the quarter ended June 30, 2024. WELL achieved record quarterly revenues of $243.1 million in Q2-2024, an increase of 42% as compared to Q2-2023 driven by acquisitions and overall organic growth of 21%. WELL achieved record Adjusted EBITDA of $30.9 million in Q2-2024, an increase of 11% as compared to Q2-2023.WELL Health Technologies Corp. shares T.WELL are trading down $0.20 at $4.44.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).